HNF4α is a novel regulator of intestinal glucose-dependent insulinotropic polypeptide

Mutations in the HNF4A gene cause MODY1 and are associated with an increased risk of Type 2 diabetes mellitus. On the other hand, incretins are hormones that potentiate reductions in blood glucose levels. Given the established role of incretin-based therapy to treat diabetes and metabolic disorders,...

Descripción completa

Detalles Bibliográficos
Autores principales: Girard, Romain, Darsigny, Mathieu, Jones, Christine, Maloum-Rami, Faïza, Gélinas, Yves, Carpentier, André C., Laplante, Mathieu, Perreault, Nathalie, Boudreau, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414548/
https://www.ncbi.nlm.nih.gov/pubmed/30862908
http://dx.doi.org/10.1038/s41598-019-41061-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414548/
https://www.ncbi.nlm.nih.gov/pubmed/30862908
http://dx.doi.org/10.1038/s41598-019-41061-z

Ejemplares similares